Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,666 | 31,667 | 34,164 | 41,773 | 45,264 |
| TOTAL | $27,896 | $31,953 | $35,437 | $42,029 | $46,034 |
| Non-Current Assets | |||||
| PPE Net | 74 | 41 | 25 | 28 | 29 |
| Other Non-Current Assets | 24 | 24 | 24 | 45 | 45 |
| TOTAL | $98 | $64 | $48 | $73 | $74 |
| Total Assets | $27,994 | $32,018 | $35,486 | $42,102 | $46,108 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 306 | 399 | 642 | 773 | 1,027 |
| Accrued Expenses | 1,327 | 1,658 | 1,029 | 727 | 257 |
| TOTAL | $1,634 | $2,057 | $1,670 | $1,500 | $1,284 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,634 | $2,057 | $1,670 | $1,500 | $1,284 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 755 | 752 | 752 | 751 | 751 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -68,237 | -64,197 | -60,103 | -53,132 | -47,864 |
| Other shareholders' equity | -41 | -41 | -41 | 0 | 0 |
| TOTAL | $26,360 | $29,961 | $33,815 | $40,602 | $44,824 |
| Total Liabilities And Equity | $27,994 | $32,018 | $35,486 | $42,102 | $46,108 |